Designing Clinical Trials for Anti-Inflammatory Therapies in Cystic Fibrosis
The inflammatory response in the CF airway begins early in the disease process and becomes persistent through life in most patients. Inflammation, which is predominantly neutrophilic, worsens airway obstruction and plays a critical role in the development of structural lung damage. While cystic fibr...
Saved in:
Main Authors: | Lucy Perrem (Author), Felix Ratjen (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Weight increase in people with cystic fibrosis on CFTR modulator therapy is mainly due to increase in fat mass
by: Marialena Mouzaki, et al.
Published: (2023) -
Multitracer Stable Isotope Quantification of Arginase and Nitric Oxide Synthase Activity in a Mouse Model of Pseudomonas Lung Infection
by: Hartmut Grasemann, et al.
Published: (2014) -
Immunoreactive trypsinogen levels in newborn screened infants with an inconclusive diagnosis of cystic fibrosis
by: Chee Y. Ooi, et al.
Published: (2019) -
Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies
by: Christie Mitri, et al.
Published: (2020) -
Editorial: Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies
by: Carla Maria Pedrosa Ribeiro, et al.
Published: (2021)